{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-22-029686","form_type":"8-K","ticker":"INBS","cik":"0001725430","company_name":"INTELLIGENT BIO SOLUTIONS INC.","filed_at":"2022-10-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:51.896659+00:00","generated_at":"2026-06-23T00:06:36.884625+00:00","sec_items":["5.02","5.03","7.01","8.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"GBS Inc. changes name to Intelligent Bio Solutions; appoints Harry Simeonidis as CEO","bullets":["Company name changed from GBS Inc. to Intelligent Bio Solutions Inc.; effective Oct 26, 2022.","Nasdaq ticker changes from GBS to INBS effective Oct 27, 2022.","Harry Simeonidis appointed President and CEO, succeeding Steven Boyages who remains Chairman.","David Jenkins and Jason Isenberg appointed to Board of Directors."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-22-029686","json":"https://secwatch.observer/filing/0001493152-22-029686.json","markdown":"https://secwatch.observer/filing/0001493152-22-029686.md","text":"https://secwatch.observer/filing/0001493152-22-029686.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1725430/000149315222029686/0001493152-22-029686-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1725430/000149315222029686/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T00:06:36.884625+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"90f4587972","claim":"Steven Boyages changed role as Interim Chief Executive Officer at INTELLIGENT BIO SOLUTIONS INC..","evidence_excerpt":"Dr. Steven Boyages, who is stepping down as the Company’s Interim Chief Executive Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1725430/000149315222029686/0001493152-22-029686-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"stepping down"},{"label":"Role","value":"Interim Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"e9bb488530","claim":"Harry Simeonidis was elected as President and Chief Executive Officer at INTELLIGENT BIO SOLUTIONS INC..","evidence_excerpt":"elected Harry Simeonidis, who currently serves as the Company’s President Asia Pacific, Sales and Marketing, as the Company’s President and Chief Executive Officer, effective as of October 26, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1725430/000149315222029686/0001493152-22-029686-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"elected"},{"label":"Role","value":"President and Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}